Fabrication of nanostructured lipid carriers ocugel for enhancing Loratadine used in treatment of COVID-19 related symptoms: statistical optimization, in-vitro , ex-vivo , and in-vivo studies evaluation.
- Citation:
- abdelmonem, R., I. E. I. Al-Samadi, R. E. M. Nashar, Bhaskara.jasti, and M. El-Nabarawi.,
"Fabrication of nanostructured lipid carriers ocugel for enhancing Loratadine used in treatment of COVID-19 related symptoms: statistical optimization, in-vitro , ex-vivo , and in-vivo studies evaluation. ",
Drug Delivery, vol. 29, issue 1, pp. 2868-2882, 2022.
